These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1493724)

  • 21. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic nephropathy: what are the diabetologist's expectations?
    Passa P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():6. PubMed ID: 10922967
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-protein diet and progression of diabetic kidney disease.
    Viberti GC
    Nephrol Dial Transplant; 1988; 3(3):334-9. PubMed ID: 3140110
    [No Abstract]   [Full Text] [Related]  

  • 24. [Risk of chronic renal failure in patients with non-insulin dependent diabetes mellitus with diabetic nephropathy and the stage of permanent proteinuria and arterial hypertension: role of clinical factors].
    Dobronravov VA
    Ter Arkh; 2000; 72(6):52-4. PubMed ID: 10900651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical and epidemiological aspects of diabetic retinopathy and its relationship with diabetic nephropathy].
    Evgrafov VIu; Mamaeva GG; Bishele NA; Liudina LI
    Vestn Oftalmol; 1996; 112(1):40-3. PubMed ID: 8659071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of hypertension on the rate of progression of chronic renal failure.
    Vetter K; Lindenau K; Krupki F; Sperscnheider H; Fröhling PT
    Scand J Urol Nephrol Suppl; 1988; 108():21-3. PubMed ID: 3163826
    [No Abstract]   [Full Text] [Related]  

  • 27. Allograft diabetic nephropathy may progress to end-stage renal disease.
    Salifu MO; Nicastri AD; Markell MS; Ghali H; Sommer BG; Friedman EA
    Pediatr Transplant; 2004 Aug; 8(4):351-6. PubMed ID: 15265161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors in the development and progression of end-stage renal failure, the 21st century epidemic].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(1):9-15. PubMed ID: 11344969
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetic nephropathy: physiopathology and clinical course].
    Macía Heras M; Macía Jerez M; Coronel F
    Nefrologia; 2001; 21 Suppl 3():24-31. PubMed ID: 11642203
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolonged dietary protein restriction in diabetic nephropathy.
    Evanoff G; Thompson C; Brown J; Weinman E
    Arch Intern Med; 1989 May; 149(5):1129-33. PubMed ID: 2719506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK; Epstein M
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract]   [Full Text] [Related]  

  • 34. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current issues in the diagnosis and therapy of diabetic nephropathy].
    de Châtel R; Mogyorósi A; Ziyadeh FN
    Orv Hetil; 1997 Jan; 138(4):187-93. PubMed ID: 9072751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physiopathological approach to the therapy of arterial hypertension in diabetic nephropathy].
    Cannella G; Scolari F; Brignani A; Maiorca R
    Minerva Nefrol; 1982; 29(3 Suppl):37-44. PubMed ID: 6128701
    [No Abstract]   [Full Text] [Related]  

  • 37. [Eye fundus of the diabetic patient with nephropathy and hypertensive retinopathy. Macroangiopathic complications].
    Leys AM
    Bull Soc Belge Ophtalmol; 1995; 256():49-59. PubMed ID: 8581231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 39. [Arterial hypertension and diabetic nephropathy].
    Chaignon M; Guedon J
    J Mal Vasc; 1992; 17(4):311-4. PubMed ID: 1494060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.
    Meloni C; Tatangelo P; Cipriani S; Rossi V; Suraci C; Tozzo C; Rossini B; Cecilia A; Di Franco D; Straccialano E; Casciani CU
    J Ren Nutr; 2004 Oct; 14(4):208-13. PubMed ID: 15483780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.